The groundbreaking success of Sildenafil undeniably reshaped the medication landscape, but betting in companies primarily reliant on unbranded versions presents a uncertain picture. While early returns were substantial, the expiration of patents and the appearance of less expensive alternatives have diminished market share. Consequently, a thoro… Read More